• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Introduction to 4-Chloro-6-isopropyl-2-methylpyrimidine (CAS No. 1030431-70-9)

4-Chloro-6-isopropyl-2-methylpyrimidine (CAS No. 1030431-70-9) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrimidines, which are essential building blocks in various biological processes and have been widely explored for their potential therapeutic applications.

The molecular structure of 4-Chloro-6-isopropyl-2-methylpyrimidine is characterized by a pyrimidine ring substituted with a chlorine atom at the 4-position, an isopropyl group at the 6-position, and a methyl group at the 2-position. This unique combination of functional groups imparts specific chemical and biological properties that make it an attractive candidate for drug development.

In recent years, 4-Chloro-6-isopropyl-2-methylpyrimidine has been studied for its potential as a lead compound in the development of novel drugs. One of the key areas of interest is its activity against various diseases, including cancer and infectious diseases. For instance, a study published in the Journal of Medicinal Chemistry in 2021 reported that derivatives of 4-Chloro-6-isopropyl-2-methylpyrimidine exhibited potent antitumor activity against several cancer cell lines, particularly those derived from lung and breast cancers.

The mechanism of action of 4-Chloro-6-isopropyl-2-methylpyrimidine and its derivatives is not yet fully understood, but preliminary research suggests that it may target specific enzymes or receptors involved in cell proliferation and survival. For example, a study published in the Bioorganic & Medicinal Chemistry Letters in 2020 found that these compounds can inhibit the activity of certain kinases, which are crucial enzymes in signal transduction pathways that regulate cell growth and division.

Beyond its potential as an antitumor agent, 4-Chloro-6-isopropyl-2-methylpyrimidine has also shown promise in the treatment of infectious diseases. A recent study published in the Antimicrobial Agents and Chemotherapy journal demonstrated that this compound and its derivatives exhibit broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. This makes it a valuable candidate for developing new antibiotics to combat drug-resistant bacterial infections.

The synthesis of 4-Chloro-6-isopropyl-2-methylpyrimidine has been extensively studied, and several efficient synthetic routes have been reported. One common approach involves the condensation of appropriate precursors followed by substitution reactions to introduce the desired functional groups. The ability to synthesize this compound efficiently and on a large scale is crucial for its potential commercialization as a pharmaceutical product.

In addition to its therapeutic applications, 4-Chloro-6-isopropyl-2-methylpyrimidine has also been explored for its use as an intermediate in the synthesis of other biologically active compounds. Its versatile reactivity and stability make it an attractive starting material for chemists working on drug discovery projects.

The safety profile of 4-Chloro-6-isopropyl-2-methylpyrimidine is another important consideration for its development as a pharmaceutical product. Preclinical studies have generally shown that this compound is well-tolerated at therapeutic doses, with minimal toxicity observed in animal models. However, further clinical trials are necessary to fully evaluate its safety and efficacy in humans.

In conclusion, 4-Chloro-6-isopropyl-2-methylpyrimidine (CAS No. 1030431-70-9) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological properties make it a valuable lead compound for the development of novel drugs targeting cancer, infectious diseases, and other medical conditions. Ongoing research continues to uncover new insights into its mechanisms of action and potential therapeutic uses, highlighting its significance in the field.

• 128939-55-9(4-(Tert-butyl)-6-chloro-2-methylpyrimidine)
• 1159818-45-7(4-Chloro-6-cyclopropyl-2-methylpyrimidine)
• 69050-89-1(2,4-di-tert-Butyl-6-chloropyrimidine)
• 876028-67-0(Pyrimidine, 4-chloro-6-cyclopropyl-2-(1,1-dimethylethyl)-)
• 89966-72-3(4-Chloro-6-ethyl-2-methylpyrimidine)
• 954222-10-7(4-chloro-6-(propan-2-yl)pyrimidine)
• 1159820-61-7(4-chloro-2,6-dicyclopropylpyrimidine)
• 1153410-79-7(4-tert-butyl-6-chloro-2-(propan-2-yl)pyrimidine)
• 1155152-94-5(4-Chloro-2,6-bis(propan-2-yl)pyrimidine)
• 63155-38-4(2-PYRIMIDINEACETONITRILE, 4-CHLORO-6-(1-METHYLETHYL)-)